Logo

Tepnel to Provide DNA-Extraction Services for AstraZeneca

May 04, 2006

NEW YORK, May 4 (GenomeWeb News) - Tepnel Life Sciences said today that it has signed a global agreement to provide DNA-extraction services for AstraZeneca.

 

Tepnel said it has been appointed a "preferred supplier" to AstraZeneca under the terms of the agreement, and will have the "opportunity to compete for further business."

 

Financial terms of the agreement were not disclosed.

Breaking News
The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.